Menopausal symptoms and risk factors for cardiovascular disease in postmenopause

By Cagnacci A.   Cannoletta M.   Palma F.   Zanin R.   Xholli A.   Volpe A.  

Climacteric, Vol. 15, Iss. 2, 2012-04 ,pp. : 157-162

Informa Healthcare

Access to resources Recommend Favorite

Non-hormonal management of vasomotor symptoms

By Sassarini J.   Lumsden M. A.  

Climacteric, Vol. 16, Iss. 1, 2013-08 ,pp. : 31-36

Informa Healthcare

Access to resources Recommend Favorite

Long-term administration of tibolone plus gonadotropin-releasing hormone agonist for the treatment of uterine leiomyomas: effectiveness and effects on vasomotor symptoms, bone mass, and lipid profiles - influence on markers of cardiovascular disease

By Palomba S.   Affinito P.   Di Carlo C.   Bifulco G.   Nappi C.  

Fertility and Sterility, Vol. 72, Iss. 5, 1999-11 ,pp. : 889-895

Elsevier

Access to resources Recommend Favorite

Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms

By Bouchard P.   Panay N.   de Villiers T. J.   Vincendon P.   Bao W.   Cheng R. J.   Constantine G.  

Climacteric, Vol. 15, Iss. 1, 2012-02 ,pp. : 12-20

Informa Healthcare

Access to resources Recommend Favorite

Self-care actions taken for vasomotor symptoms by some postmenopausal Kelantanese women

By Dhillon H. -K.   Singh H. J.   Nik Mahmood N.Mohd Zaki   Ghaffar N. A.  

Climacteric, Vol. 11, Iss. 6, 2008-01 ,pp. : 518-524

Informa Healthcare

Access to resources Recommend Favorite